What is the need and why is it time for innovative models for understanding lung repair and regeneration?

DJ Weiss - Frontiers in Pharmacology, 2023 - frontiersin.org
Advances in tissue engineering continue at a rapid pace and have provided novel
methodologies and insights into normal cell and tissue homeostasis, disease pathogenesis …

[HTML][HTML] Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome

TY Liang, LH Lu, SY Tang, ZH Zheng… - World Journal of Stem …, 2023 - ncbi.nlm.nih.gov
Acute respiratory distress syndrome (ARDS) is a common and clinically devastating disease
that causes respiratory failure. Morbidity and mortality of patients in intensive care units are …

Umbilical Cord-Mesenchymal Stem Cell Therapy for COVID-19 Related Acute Respiratory Distress Syndrome: A Mini-Review

B Monterroso, RL Martin, D Alonso… - … and Practice of …, 2023 - journal.ppcr.org
Introduction: Acute respiratory distress syndrome (ARDS) is the leading cause of death
among coronavirus disease 2019 (COVID-19) patients, mainly due to the cytokine storm and …

[PDF][PDF] Stem cells: a promising therapeutic target for COVID-19

TH Leyla, X Nan - Stem Cell Discovery, 2022 - escholarship.org
A large variety of therapeutic products have been developed as vaccines or treatments of
COVID-19 infection. Meanwhile SARS-CoV-2 continues to mutate and spread. The severe …

Hyperactivity of platelets and increased megakaryopoiesis in COVID-19 patients with acute respiratory distress syndrome

L Wang, H Liu, J Liu, H Yuan, C Wu, X Li, K Xu, J Hong… - Med-X, 2023 - Springer
Abstract The Severe Acute Respiratory Syndrome (SARS)-CoV-2-induced Coronavirus
Disease 2019 (COVID-19) pandemic has caused an overwhelming influence on public …

[HTML][HTML] Emerging Role and Therapeutic Application of Mesenchymal Stem Cell (MSC) and MSC-Derived Exosome in Coronavirus Disease-2019 (COVID-19) …

Y Shi, C Yu, Z Yu, J Shang, Q Yang… - Recent Update on …, 2023 - intechopen.com
Over the past few years, the coronavirus disease-2019 (COVID-19) pandemic has infected
billions of people worldwide. Most patients infected with COVID-19 present with fever …

[HTML][HTML] Immunomodulation of Antiviral Response by Mesenchymal Stromal Cells (MSCs)

S Raj, HC Chandramoorthy - 2023 - intechopen.com
Mesenchymal stromal cells (MSCs) are known for their immunomodulatory properties, and
their role in antiviral response is poorly understood. The susceptibility of the MSCs to viral …

Análise compreensiva da resposta imune às infecções por ZIKV e SARS-CoV-2 em diferentes contextos patológicos

IS Filgueiras - 2023 - teses.usp.br
Análise compreensiva da resposta imune às infecções por ZIKV e SARS-CoV-2 em
diferentes contextos patológicos Vírus é um assunto de extrema relevância para a saúde …

[PDF][PDF] Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: A double-blind randomised controlled trial

R Duarte, ME Martínez-Muñoz, C Payares-Herrera… - 2023 - scholar.archive.org
Mesenchymal stromal cells (MSC) have immunomodulatory and tissue-regenerative
properties and have shown promising results in acute respiratory distress syndrome (ARDS) …

Immunoregulatory effects of human amniotic mesenchymal stem cells and their exosomes on human peripheral blood mononuclear cells.

X Tian, X He, S Qian, R Zou, K Chen, C Zhu, Z Yin - Biocell, 2023 - search.ebscohost.com
Background: The immunomodulatory effects of mesenchymal stem cells (MSCs) and their
exosomes have been receiving increasing attention. This study investigated the …